Astronomical prices of patented anti-cancer dugs have become a subject of great concern not just in India. It is becoming an issue across the world. After issuing the first ever Compulsory License (CL) for Nexavar of Bayer in India, the … Continue reading
Astronomical Prices of Patented Cancer Drugs: A Solution in Sight?
Reply